The inhibition of SCN function could improve the inflammatory response after myocardial infarction and promote cardiac repair by upregulating BMAL1 to promote insulin-like growth factor 2 (Igf2) expression and inducing macrophage conversion to an anti-inflammatory phenotype [78]. This evidence concerns the gene BMAL1 and myocardial infarction.